Chronic obstructive pulmonary disease in HIV

References

• Bigna JJ, Kenne AM, Asangbeh SL, et al. Prevalence of chronic obstructive pulmonary disease in the global population with HIV: a systematic review and meta-analysis. Lancet Glob Health. 2018 Feb;;6(2):e193–e202.
   PubMed Web of Science ®Google Scholar
• GOLD. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease, 2020 report. 2020 [ Access date: 2020 Sept 6]
   Google Scholar
• Institute for Health Metrics and Evaluation. Global burden of disease: University of Washington. [updated 2020;Access date: september 1, 2020]. Available from: https. //vizhub.healthdata.org/gbd-compare/; 2020.
   Google Scholar
• Magalhaes MG, Greenberg B, Hansen H, et al. Comorbidities in older patients with HIV: a retrospective study. JADA. 2007;138(11):1468–1475.
   PubMed Web of Science ®Google Scholar
• Crothers K, Butt AA, Gibert CL, et al. Increased COPD among HIV-positive compared to HIV-negative veterans. Chest. 2006 Nov;;130(5):1326–1333.
   PubMed Web of Science ®Google Scholar
• Morris A, George MP, Crothers K, et al. HIV and chronic obstructive pulmonary disease: is it worse and why? Proc Am Thorac Soc. 2011 Jun;;8(3):320–325.
   PubMedGoogle Scholar
• Madeddu G, Fois AG, Calia GM, et al. Chronic obstructive pulmonary disease: an emerging comorbidity in HIV-infected patients in the HAART era? Infection. 2013 Apr;;41(2):347–353.
   PubMed Web of Science ®Google Scholar
• Schouten J, Wit FW, Stolte IG, et al. Cross-sectional comparison of the prevalence of age-associated comorbidities and their risk factors between HIV-infected and uninfected individuals: the AGEhIV cohort study. Clin Infect Dis. 2014 Dec 15;59(12):1787–1797.
   PubMed Web of Science ®Google Scholar
• Petrache I, Diab K, Knox KS, et al. HIV associated pulmonary emphysema: a review of the literature and inquiry into its mechanism. Thorax. 2008 May;;63(5):463–469.
   PubMed Web of Science ®Google Scholar
• Crothers K, Huang L, Goulet JL, et al. HIV infection and risk for incident pulmonary diseases in the combination antiretroviral therapy era. Am J Respir Crit Care Med. 2011 Feb 1;183(3):388–395.
   PubMed Web of Science ®Google Scholar
• Drummond MB, Merlo CA, Astemborski J, et al. The effect of HIV infection on longitudinal lung function decline among IDUs: a prospective cohort. AIDS. 2013 May 15;27(8):1303–1311.
   PubMed Web of Science ®Google Scholar
• Drummond MB, Kunisaki KM, Huang L. Obstructive lung diseases in HIV: a clinical review and identification of key future research needs. Semin Respir Crit Care Med. 2016 Apr;;37(2):277–288.
   PubMed Web of Science ®Google Scholar
• Diaz PT, King MA, Pacht ER, et al. Increased susceptibility to pulmonary emphysema among HIV-seropositive smokers. Ann Intern Med. 2000 Mar 7;132(5):369–372.
   PubMed Web of Science ®Google Scholar
• George MP, Kannass M, Huang L, et al. Respiratory symptoms and airway obstruction in HIV-infected subjects in the HAART era. PLoS One. 2009 Jul 21;4(7):e6328.
   PubMed Web of Science ®Google Scholar
• Cui Q, Carruthers S, McIvor A, et al. Effect of smoking on lung function, respiratory symptoms and respiratory diseases amongst HIV-positive subjects: a cross-sectional study. AIDS Res Ther. 2010 Mar;19(7):6.
   Google Scholar
• Gingo MR, George MP, Kessinger CJ, et al. Pulmonary function abnormalities in HIV-infected patients during the current antiretroviral therapy era. Am J Respir Crit Care Med. 2010 Sep 15;182(6):790–796.
   PubMed Web of Science ®Google Scholar
• Hirani A, Cavallazzi R, Vasu T, et al. Prevalence of obstructive lung disease in HIV population: a cross sectional study. Respir Med. 2011 Nov;;105(11):1655–1661.
   PubMed Web of Science ®Google Scholar
• Kristoffersen US, Lebech AM, Mortensen J, et al. Changes in lung function of HIV-infected patients: a 4.5-year follow-up study. Clin Physiol Funct Imaging. 2012 Jul;;32(4):288–295.
   PubMed Web of Science ®Google Scholar
• Crothers K, McGinnis K, Kleerup E, et al. HIV infection is associated with reduced pulmonary diffusing capacity. J Acquir Immune Defic Syndr. 2013 Nov 1;64(3):271–278.
   PubMed Web of Science ®Google Scholar
• Fitzpatrick ME, Gingo MR, Kessinger C, et al. HIV infection is associated with diffusing capacity impairment in women. J Acquir Immune Defic Syndr. 2013 Nov 1;64(3):284–288.
   PubMed Web of Science ®Google Scholar
• Kendall CE, Wong J, Taljaard M, et al. A cross-sectional, population-based study measuring comorbidity among people living with HIV in Ontario. BMC Public Health. 2014 Feb ;13(14):161.
   Google Scholar
• Campo M, Oursler KK, Huang L, et al. Association of chronic cough and pulmonary function with 6-minute walk test performance in HIV infection. J Acquir Immune Defic Syndr. 2014 Apr 15;65(5):557–563.
   PubMed Web of Science ®Google Scholar
• Rahmanian SD, Wood KL, Lin S, et al. Gender differences in pulmonary function, respiratory symptoms, and macrophage proteomics among HIV-infected smokers. Scientifica (Cairo). 2014;2014:613689.
   PubMedGoogle Scholar
• Nakamura H, Tateyama M, Tasato D, et al. The prevalence of airway obstruction among Japanese HIV-positive male patients compared with general population; a case-control study of single center analysis. J Infect Chemother. 2014 Jun;;20(6):361–364.
   PubMed Web of Science ®Google Scholar
• Samperiz G, Guerrero D, Lopez M, et al. Prevalence of and risk factors for pulmonary abnormalities in HIV-infected patients treated with antiretroviral therapy. HIV Med. 2014 Jul;;15(6):321–329.
   PubMed Web of Science ®Google Scholar
• Guaraldi G, Besutti G, Scaglioni R, et al. The burden of image based emphysema and bronchiolitis in HIV-infected individuals on antiretroviral therapy. PLoS One. 2014 Oct;;9(10):e109027.
   PubMed Web of Science ®Google Scholar
• Simonetti JA, Gingo MR, Kingsley L, et al. Pulmonary function in HIV-infected recreational drug users in the era of anti-retroviral therapy. J AIDS Clin Res. 2014 Nov;5(11):11. .
   Google Scholar
• Attia EF, Akgun KM, Wongtrakool C, et al. Increased risk of radiographic emphysema in HIV is associated with elevated soluble CD14 and nadir CD4. Chest. 2014 Dec;146(6):1543–1553.
   PubMed Web of Science ®Google Scholar
• Makinson A, Hayot M, Eymard-Duvernay S, et al. High prevalence of undiagnosed COPD in a cohort of HIV-infected smokers. Eur Respir J. 2015 Mar;;45(3):828–831.
   PubMed Web of Science ®Google Scholar
• Kunisaki KM, Niewoehner DE, Collins G, et al. Pulmonary function in an international sample of HIV-positive, treatment-naive adults with CD4 counts > 500 cells/muL: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial. HIV Med. 2015 Apr;16(Suppl 1):119–128.
   PubMedGoogle Scholar
• Drummond MB, Huang L, Diaz PT, et al. Factors associated with abnormal spirometry among HIV-infected individuals. AIDS. 2015 Aug 24;29(13):1691–1700.
   PubMed Web of Science ®Google Scholar
• Nimmo C, Capocci S, Honeyborne I, et al. Airway bacteria and respiratory symptoms are common in ambulatory HIV-positive UK adults. Eur Respir J. 2015 Oct;;46(4):1208–1211.
   PubMed Web of Science ®Google Scholar
• Depp TB, McGinnis KA, Kraemer K, et al. Risk factors associated with acute exacerbation of chronic obstructive pulmonary disease in HIV-infected and uninfected patients. AIDS. 2016 Jan 28;30(3):455–463.
   PubMed Web of Science ®Google Scholar
• Leader JK, Crothers K, Huang L, et al. Risk factors associated with quantitative evidence of lung emphysema and fibrosis in an HIV-infected cohort. J Acquir Immune Defic Syndr. 2016 Apr 1;71(4):420–427.
   PubMed Web of Science ®Google Scholar
• Akgun KM, Tate JP, Oursler KK, et al. Association of chronic obstructive pulmonary disease with frailty measurements in HIV-infected and uninfected Veterans. AIDS. 2016 Sep 10;30(14):2185–2193.
   PubMed Web of Science ®Google Scholar
• Ghadaki B, Kronfli N, Vanniyasingam T, et al. Chronic obstructive pulmonary disease and HIV: are we appropriately screening? AIDS Care. 2016 Oct;;28(10):1338–1343.
   PubMed Web of Science ®Google Scholar
• Risso K, Guillouet-de-Salvador F, Valerio L, et al. COPD in HIV-Infected patients: CD4 cell count highly correlated. PLoS One. 2017 Jan 5;12(1):e0169359.
   PubMed Web of Science ®Google Scholar
• Triplette M, Attia EF, Akgun KM, et al. A low peripheral blood CD4/CD8 ratio is associated with pulmonary emphysema in HIV. PLoS One. 2017 Jan 25;12(1):e0170857.
   PubMed Web of Science ®Google Scholar
• Makinson A, Hayot M, Eymard-Duvernay S, et al. HIV is associated with airway obstruction: a matched controlled study. AIDS. 2018 Jan 14;32(2):227–232.
   PubMed Web of Science ®Google Scholar
• Gingo MR, Nouraie M, Kessinger CJ, et al. Decreased lung function and all-cause mortality in HIV-infected individuals. Ann Am Thorac Soc. 2018 Feb;;15(2):192–199.
   PubMed Web of Science ®Google Scholar
• Triplette M, Justice A, Attia EF, et al. Markers of chronic obstructive pulmonary disease are associated with mortality in people living with HIV. AIDS. 2018 Feb 20;32(4):487–493.
   PubMed Web of Science ®Google Scholar
• Ronit A, Kristensen T, Hoseth VS, et al. Computed tomography quantification of emphysema in people living with HIV and uninfected controls. Eur Respir J. 2018 Jul;52(1):1. .
   Web of Science ®Google Scholar
• Li Y, Nouraie SM, Kessinger C, et al. Factors associated with progression of lung function abnormalities in HIV-infected individuals. J Acquir Immune Defic Syndr. 2018 Dec 1;79(4):501–509.
   PubMed Web of Science ®Google Scholar
• Costiniuk CT, Nitulescu R, Saneei Z, et al. Prevalence and predictors of airflow obstruction in an HIV tertiary care clinic in montreal, canada: a cross-sectional study. HIV Med. 2019 Mar;;20(3):192–201.
   PubMed Web of Science ®Google Scholar
• Jeon D, Chang EG, McGing M, et al. Pneumoproteins are associated with pulmonary function in HIV-infected persons. PLoS One. 2019;14(10):e0223263.
   PubMed Web of Science ®Google Scholar
• Kunisaki KM, Nouraie M, Jensen RL, et al. Lung function in men with and without HIV. AIDS. 2020 Jul 1;34(8):1227–1235.
   PubMed Web of Science ®Google Scholar
• Onyedum CC, Chukwuka JC, Onwubere BJ, et al. Respiratory symptoms and ventilatory function tests in nigerians with HIV infection. Afr Health Sci. 2010 Jun;;10(2):130–137.
   PubMed Web of Science ®Google Scholar
• Pefura-Yone EW, Fodjeu G, Kengne AP, et al. Prevalence and determinants of chronic obstructive pulmonary disease in HIV infected patients in an african country with low level of tobacco smoking. Respir Med. 2015 Feb;;109(2):247–254.
   PubMed Web of Science ®Google Scholar
• Akanbi MO, Taiwo BO, Achenbach CJ, et al. HIV Associated Chronic Obstructive Pulmonary Disease in Nigeria. J AIDS Clin Res. 2015 May;6(5):5. .
   Google Scholar
• Gupte AN, Wong ML, Msandiwa R, et al. Factors associated with pulmonary impairment in HIV-infected South African adults. PLoS One. 2017;12(9):e0184530.
   PubMed Web of Science ®Google Scholar
• North CM, Allen JG, Okello S, et al. HIV Infection, pulmonary tuberculosis, and COPD in rural uganda: a cross-sectional study. Lung. 2018 Feb;;196(1):49–57.
   PubMed Web of Science ®Google Scholar
• Attia EF, Maleche-Obimbo E, West TE, et al. Adolescent age is an independent risk factor for abnormal spirometry among people living with HIV in Kenya. AIDS. 2018 Jun 19;32(10):1353–1359.
   PubMed Web of Science ®Google Scholar
• Varkila MRJ, Vos AG, Barth RE, et al. The association between HIV infection and pulmonary function in a rural African population. PLoS One. 2019;14(1):e0210573.
   PubMed Web of Science ®Google Scholar
• Kayongo A, Wosu AC, Naz T, et al. Chronic obstructive pulmonary disease prevalence and associated factors in a setting of well-controlled HIV, a cross-sectional study. COPD. 2020 Jun;;17(3):297–305.
   PubMedGoogle Scholar
• Morris A, Huang L, Bacchetti P, et al. Permanent declines in pulmonary function following pneumonia in human immunodeficiency virus-infected persons. Am J Respir Crit Care Med. 2000;162(2):612–616.
   PubMed Web of Science ®Google Scholar
• Cribbs SK, Crothers K, Morris A. Pathogenesis of HIV-related lung disease: immunity, infection, and inflammation. Physiol Rev. 2020 Apr 1;100(2):603–632.
   PubMed Web of Science ®Google Scholar
• Deeks SG, Tracy R, Douek DC. Systemic effects on inflammation on health during chronic HIV infection. Immunity. 2013;39(4):633–645.
   PubMed Web of Science ®Google Scholar
• Hunt PW, Lee SA, Siedner MJ. Immunologic biomarkers, morbidity, and mortality in treated HIV infection. J Infect Dis. 2016;214(suppl 2):S44–S50.
   PubMed Web of Science ®Google Scholar
• Head BM, Mao R, Keynan Y, et al. Inflammatory mediators and lung abnormalities in HIV: A systematic review. PLoS One. 2019;14(12):e0226347.
   PubMed Web of Science ®Google Scholar
• Chung NPY, Ou X, Khan KMF, et al. HIV reprograms human airway basal stem/progenitor cells to acquire a tissue-destructive phenotype. Cell Rep. 2017;19(6):1091–1100.
   PubMed Web of Science ®Google Scholar
• Cohn LB, Chomont N, Deeks SG. The biology of HIV-1 latent reservoir and implications for cure strategies. Cell Host Microbe. 2020;27(4):519–530.
   PubMed Web of Science ®Google Scholar
• Almodovar S. The complexity of HIV persistence and pathogenesis in the lung under antiretroviral therapy: challenges beyond AIDS. Viral Immunol. 2014;27(5):186–199.
   PubMed Web of Science ®Google Scholar
• Joseph SB, Arrildt KT, Swanstrom AE, et al. Quantification of entry phenotypes of macrophage-tropic HIV-1 across a wide range of CD4 densities. J Virol. 2014;88(4):1858–1869.
   PubMed Web of Science ®Google Scholar
• Kruize Z, Koostra NA. The role of macrophages in HIV-1 persistence and pathogenesis. Front Microbiol. 2019;10:2828.
   PubMed Web of Science ®Google Scholar
• Röszer T. Understanding the biology of self-renewing macrophages. Cells. 2018;7(8):103.
   Web of Science ®Google Scholar
• Vlahos R, Bozinovski S. Role of alveolar macrophages in chronic obstructive pulmonary disease. Front Immunol. 2014;5:435.
   PubMed Web of Science ®Google Scholar
• Wong ME, Jaworowski A, Hearps AC. The HIV reservoir in monocytes and macrophages. Front Immunol. 2019;10:1435.
   PubMed Web of Science ®Google Scholar
• Jambo KC, Banda DH, Kankwatira AM, et al. Small alveolar macrophages are infected preferentially by HIV and exhibit impaired phagocytic function. Mucosal Immunol. 2014;7(5):1116–1126.
   PubMed Web of Science ®Google Scholar
• Cribbs SK, Lennox J, Caliendo AM, et al. Healthy HIV-1-infected individuals on highly active antiretroviral therapy harbor HIV-1 in their alveolar macrophages. AIDS Res Hum Retroviruses. 2015;31(1):64–70. .
   PubMed Web of Science ®Google Scholar
• DiNapoli SR, Ortiz AM, Wu F, et al. Tissue-resident macrophages can contain replication-competent virus in antiretroviral-naive, SIV-infected Asian macaques. JCI Insight. 2017 Feb 23;2(4):e91214.
   PubMed Web of Science ®Google Scholar
• Costiniuk CT, Salahuddin S, Farnos O, et al. HIV persistence in mucosal CD4+ T cells within the lungs of adults receiving long-term suppressive antiretroviral therapy. AIDS. 2018;32:2279–2289.
   PubMed Web of Science ®Google Scholar
• Cai Y, Sugimoto C, Arainga M, et al. Preferential destruction of interstitial macrophages over alveolar macrophages as a cause of pulmonary disease in simian immunodeficiency virus-infected rhesus macaques. J Immunol. 2015 Nov 15;195(10):4884–4891.
   PubMed Web of Science ®Google Scholar
• Epelman S, Lavine KJ, Randolph GJ. Origin and functions of tissue macrophages. Immunity. 2014;41(1):21–35.
   PubMed Web of Science ®Google Scholar
• Avalos CR, Price SL, Forsyth ER, et al. Quantitation of productively infected monocytes and macrophages of simian immunodeficiency viruse-infected macaques. J Virol. 2016;90(12):5643–5656.
   PubMed Web of Science ®Google Scholar
• Abreu CM, Veenhuis RT, Avalos CR, et al. Infectious virus persists in CD4+ T cells and macrophages in antiretroviral therapy-suppressed simian immunodeficiency virus-infected macaques. J Virol. 2019;93(15):e00065–19.
   PubMed Web of Science ®Google Scholar
• Evans DT, Silvestri G. Nonhuman primate models in AIDS research. Curr Opin HIV AIDS. 2013;8:255–261.
   PubMed Web of Science ®Google Scholar
• Olloquequi J, Jaime S, Parra V, et al. Comparative analysis of COPD associated with tobacco smoking, biomass smoke exposure or both. Respir Res. 2018;19:13.
   PubMed Web of Science ®Google Scholar
• Falasca F, Di Carlo D, De Vito C, et al. Evaluation of HIV-DNA and inflammatory markers in HIV-infected individuals with different viral load patterns. BMC Infect Dis. 2017;17(1):581.
   PubMed Web of Science ®Google Scholar
• Hernandez JC, Latz E, Urcuqui-Inchima SHIV. 1 induces the first signal to activate the NLRP3 inflammasome in monocyte-derived macrophages. Intervirology. 2014;57(1):36–42.
   PubMed Web of Science ®Google Scholar
• Guo H, Gao J, Taxman DJ, et al. 1 infection induces interleukin-1β production via TLR8 protein-dependent and NLRP3 inflammasome mechanisms in human monocytes. J Biol Chem. 2014;289(31):21716–21726.
   PubMed Web of Science ®Google Scholar
• Walsh JG, Reinke SN, Mamik MK, et al. Rapid inflammasome activation in microglia contributes to brain disease in HIV/AIDS. Retrovirology. 2014;11(1):35. 2014 05 13.
   PubMedGoogle Scholar
• Webster NL, Crowe SM. Matrix metalloproteinases, their production by monocytes and macrophages and their potential role in HIV‐related diseases. J Leukocyte Biol. 2006;80(5):1052–1066.
   PubMed Web of Science ®Google Scholar
• Kunisaki KM, Niewoehner DE, Collins G, et al. Pulmonary effects of immediate versus deferred antiretroviral therapy in HIV-positive individuals: a nested substudy within the multicentre, international, randomised, controlled Strategic Timing of Antiretroviral Treatment (START) trial. Lancet Respir Med. 2016;4(12): 980–989.
   PubMed Web of Science ®Google Scholar
• Ronit A, Lundgren J, Afzal S, et al. Airflow limitation in people living with HIV and matched uninfected controls. Thorax. 2018 May;;73(5):431–438.
   PubMed Web of Science ®Google Scholar
• Logue EC, Neff CP, Mack DG, et al. Upregulation of chitinase 1 in alveolar macrophages of HIV-infected smokers. J Immunol. 2019 Mar 1;202(5):1363–1372.
   PubMed Web of Science ®Google Scholar
• Neff CP, Logue EC, Siebert J, et al. Loss of anti-inflammatory alveolar macrophages associates with lung inflammation in untreated HIV infection. J Immunol. 2020;204(1 Supplement): 248.15–248.15.
   Web of Science ®Google Scholar
• Neff CP, Chain JL, MaWhinney S, et al. Lymphocytic alveolitis is associated with the accumulation of functionally impaired HIV-specific T cells in the lung of antiretroviral therapy-naive subjects. Am J Respir Crit Care Med. 2015 Feb 15;191(4):464–473.
   PubMed Web of Science ®Google Scholar
• Mendez R, Banerjee S, Bhattacharya SK, et al. Lung inflammation and disease: A perspective on microbial homeostasis and metabolism. IUBMB Life. 2019;71(2):152–165.
   PubMed Web of Science ®Google Scholar
• Zhou X, Li J, Guo J, et al. Gut-dependent microbial translocation induces inflammation and cardiovascular events after ST-elevation myocardial infarction. Microbiome. 2018 Apr 3;6(1):66.
   PubMedGoogle Scholar
• Yang L, Dunlap DG, Qin S, et al. Alterations in oral microbiota in HIV are related to decreased pulmonary function. Am J Respir Crit Care Med. 2020 Feb 15;201(4):445–457.
   PubMed Web of Science ®Google Scholar
• Morris A, Alexander T, Radhi S, et al. Airway obstruction is increased in pneumocystis-colonized human immunodeficiency virus-infected outpatients. Journal of Clinical Microbiology. 2009;47(11):3773–3776.
   Google Scholar
• Morris A, Sciurba FC, Norris KA. Pneumocystis: A novel pathogen in chronic obstructive pulmonary disease? COPD. 2008;5(1):43–51.
   PubMedGoogle Scholar
• Morris A, Sciurba FC, Lebedeva IP, et al. Association of chronic obstructive pulmonary disease severity and pneumocystis colonization. Am J Respir Crit Care Med. 2004 Aug 15;170(4):408–413.
   PubMed Web of Science ®Google Scholar
• Fitzpatrick ME, Tedrow JR, Hillenbrand ME, et al. Pneumocystis jirovecii colonization is associated with enhanced Th1 inflammatory gene expression in lungs of humans with chronic obstructive pulmonary disease. Microbiol Immunol. 2014 Mar;58(3):202–211.
   PubMed Web of Science ®Google Scholar
• Norris KA, Morris A, Patil S, et al. Pneumocystis colonization, airway inflammation, and pulmonary function decline in acquired immunodeficiency syndrome. Immunol Res. 2006;36(1–3):175–187.
   PubMed Web of Science ®Google Scholar
• Lichtner M, Cicconi P, Vita S, et al. Cytomegalovirus coinfection is associated with an increased risk of severe non-AIDS-defining events in a large cohort of HIV-infected patients. J Infect Dis. 2015 Jan 15;211(2):178–186.
   PubMed Web of Science ®Google Scholar
• Ramendra R, Isnard S, Lin J, et al. Cytomegalovirus Seropositivity Is Associated With Increased Microbial Translocation in People Living With Human Immunodeficiency Virus and Uninfected Controls. Clin Infect Dis. 2019;71(6):1438–1446
   Web of Science ®Google Scholar
• Wang H, Peng G, Bai J, et al. Cytomegalovirus infection and relative risk of cardiovascular disease (ischemic heart disease, stroke, and cardiovascular death): a meta-analysis of prospective studies up to 2016. J Am Heart Assoc. 2017 Jul 6;6(7):7.
   Web of Science ®Google Scholar
• van Son WJ, Tegzess AM, Hauw The T, et al. Pulmonary dysfunction is common during a cytomegalovirus infection after renal transplantation even in asymptomatic patients. Possible relationship with complement activation. Am Rev Respir Dis. 1987 Sep;;136(3):580–585.
   PubMedGoogle Scholar
• Wasilewska E, Kuziemski K, Niedoszytko M, et al. Impairment of lung diffusion capacity-a new consequence in the long-term childhood leukaemia survivors. Ann Hematol. 2019 Sep;;98(9):2103–2110.
   PubMed Web of Science ®Google Scholar
• Fitzpatrick ME, Nouraie M, Gingo MR, et al. Novel relationships of markers of monocyte activation and endothelial dysfunction with pulmonary dysfunction in HIV-infected persons. AIDS. 2016 Jun 1;30(9):1327–1339.
   PubMed Web of Science ®Google Scholar
• Hodowanec A, Williams B, Hanson B, et al. Soluble CD163 but not soluble CD14 is associated with cytomegalovirus immunoglobulin g antibody levels in virologically suppressed HIV+ individuals. J Acquir Immune Defic Syndr. 2015 Dec 15;70(5):e171–4.
   PubMed Web of Science ®Google Scholar
• Lurain NS, Hanson BA, Hotton AL, et al. The association of human cytomegalovirus with biomarkers of inflammation and immune activation in HIV-1-infected women. AIDS Res Hum Retroviruses. 2016 Feb;32(2):134–143.
   PubMed Web of Science ®Google Scholar
• Vita S, Lichtner M, Marchetti G, et al. Brief report: soluble CD163 in CMV-infected and CMV-uninfected subjects on virologically suppressive antiretroviral therapy in the ICONA cohort. J Acquir Immune Defic Syndr. 2017 Mar 1;74(3):347–352.
   PubMed Web of Science ®Google Scholar
• Hunt PW, Martin JN, Sinclair E, et al. Valganciclovir reduces T cell activation in HIV-infected individuals with incomplete CD4+ T cell recovery on antiretroviral therapy. J Infect Dis. 2011 May 15;203(10):1474–1483.
   PubMed Web of Science ®Google Scholar
• Bazzan E, Turato G, Tinè M, et al. Dual polarization of human alveolar macrophages progressively increases with smoking and COPD severity. Respir Res. 2017 Feb 23;18(1):40.
   PubMed Web of Science ®Google Scholar
• Kapellos TS, Bassler K, Aschenbrenner AC, et al. Dysregulated functions of lung macrophage populations in COPD. J Immunol Res. 2018;2018:2349045.
   PubMed Web of Science ®Google Scholar
• Staples KJ, Nicholas B, McKendry RT, et al. Viral infection of human lung macrophages increases PDL1 expression via IFNβ. PLoS One. 2015;10(3):e0121527.
   PubMed Web of Science ®Google Scholar
• Stoll P, Virchow JC, The LM. PD-1–PD-L1 axis in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2016;194(5): 644–644.
   PubMed Web of Science ®Google Scholar
• Wilkinson TMA. Immune checkpoints in chronic obstructive pulmonary disease. Eur Respir Rev. 2017;26(144):170045.
   PubMed Web of Science ®Google Scholar
• Hunegnaw R, Mushtaq Z, Enyindah-Asonye G, et al. Dysfunction and increased PD-1 expression during chronic SIV infection of rhesus macaques. Front Immunol. 2019;10:1537.
   PubMed Web of Science ®Google Scholar
• Rodríguez-García M, Porichis F, de Jong OG, et al. Expression of PD-L1 and PD-L2 on human macrophages is up-regulated by HIV-1 and differentially modulated by IL-10. J Leukoc Biol. 2011 Apr;89(4):507–515.
   PubMed Web of Science ®Google Scholar
• Triplette M, Crothers K, Attia EF. Non-infectious pulmonary diseases and HIV. Curr HIV/AIDS Rep. 2016 Jun;;13(3):140–148.
   PubMed Web of Science ®Google Scholar
• Drummond MB, Kirk GD. HIV-associated obstructive lung diseases: insights and implications for the clinician. Lancet Respir Med. 2014 Jul;;2(7):583–592.
   PubMed Web of Science ®Google Scholar
• Morris A, Gingo MR, George MP, et al. Cardiopulmonary function in individuals with HIV infection in the antiretroviral therapy era. AIDS. 2012 Mar 27;26(6):731–740.
   PubMed Web of Science ®Google Scholar
• Kuhlman JE, Knowles MC, Fishman EK, et al. Premature bullous pulmonary damage in AIDS: CT diagnosis. Radiology. 1989;173(1):23–26.
   PubMed Web of Science ®Google Scholar
• Diaz PT, Clanton TL, Pacht ER. Emphysema-like pulmonary disease associated with human immunodeficiency virus infection. Ann Intern Med. 1992Jan15;116(2):124–128.
   PubMed Web of Science ®Google Scholar
• Diaz PT, Wewers MD, King M, et al. Regional differences in emphysema scores and BAL glutathione levels in HIV-infected individuals. Chest. 2004 Nov;;126(5):1439–1442.
   PubMed Web of Science ®Google Scholar
• King MA, Neal DE, St John R, et al. Bronchial dilatation in patients with HIV infection: CT assessment and correlation with pulmonary function tests and findings at bronchoalveolar lavage. AJR Am J Roentgenol. 1997 Jun;;168(6):1535–1540.
   PubMed Web of Science ®Google Scholar
• Clausen E, Wittman C, Gingo M, et al. Chest computed tomography findings in HIV-infected individuals in the era of antiretroviral therapy. PLoS One. 2014;9(11):e112237.
   PubMed Web of Science ®Google Scholar
• Hopewell PC, Luce JM. Pulmonary involvement in the acquired immunodeficiency syndrome. Chest. 1985 Jan;;87(1):104–112.
   PubMed Web of Science ®Google Scholar
• Shaw RJ, Roussak C, Forster SM, et al. Lung function abnormalities in patients infected with the human immunodeficiency virus with and without overt pneumonitis. Thorax. 1988;43(6):436–440.
   PubMed Web of Science ®Google Scholar
• Camus F, de Picciotto C, Gerbe J, et al. Pulmonary function tests in HIV-infected patients. AIDS. 1993 Aug;;7(8):1075–1079.
   PubMed Web of Science ®Google Scholar
• Triplette M, Attia E, Akgun K, et al. The differential impact of emphysema on respiratory symptoms and 6-minute walk distance in HIV infection. J Acquir Immune Defic Syndr. 2017 Jan 1;74(1):e23–e29.
   PubMed Web of Science ®Google Scholar
• MacDonald DM, Melzer AC, Collins G, et al. Smoking and accelerated lung function decline in HIV-positive individuals: a secondary analysis of the start pulmonary substudy. J Acquir Immune Defic Syndr. 2018 Nov 1;79(3):e85–e92.
   PubMed Web of Science ®Google Scholar
• Mitchell DM, Fleming J, Harris JRW, et al. Serial pulmonary function tests in the diagnosis of P. carinii pneumonia. Eur Respir J. 1993;6:823–827.
   PubMed Web of Science ®Google Scholar
• French PD, Cunningham DA, Fleming J, et al. Low carbon monoxide transfer factor (TLCO) in HIV-infected patients without lung disease. Respir Med. 1992;86:253–256.
   PubMed Web of Science ®Google Scholar
• Kvale PA, Rosen MJ, Hopewell PC, et al. A decline in the pulmonary diffusing capacity does not indicate opportunistic lung disease in asymptomatic persons infected with the human immunodeficiency virus. Am Rev Respir Dis. 1993;148:390–395.
   PubMedGoogle Scholar
• Diaz PT, King MA, Pacht ER, et al. The pathophysiology of pulmonary diffusion impairment in human immunodeficiency virus infection. Am J Respir Crit Care Med. 1999 Jul;;160(1):272–277.
   PubMed Web of Science ®Google Scholar
• Gingo MR, He J, Wittman C, et al. Contributors to diffusion impairment in HIV-infected persons. Eur Respir J. 2014 Jan;;43(1):195–203.
   PubMed Web of Science ®Google Scholar
• Leung JM, Malagoli A, Santoro A, et al. Emphysema distribution and diffusion capacity predict emphysema progression in human immunodeficiency virus infection. PLoS One. 2016;11(11):e0167247.
   PubMed Web of Science ®Google Scholar
• Islam M, Ramesh N, Kolman S, et al. Association between CD4(+), viral load, and pulmonary function in HIV. Lung. 2017 Oct;195(5):635–642.
   PubMed Web of Science ®Google Scholar
• Nieman RB, Fleming J, Coker RJ, et al. Reduced carbon monoxide transfer factor (TLCO) in human immunodeficiency virus type I (HIV-1) infection as a predictor for faster progression to AIDS. Thorax. 1993;48:481–485.
   PubMed Web of Science ®Google Scholar
• Chandra D, Gupta A, Fitzpatrick M, et al. Lung function, coronary artery disease, and mortality in HIV. Ann Am Thorac Soc. 2019 Jun;;16(6):687–697.
   PubMed Web of Science ®Google Scholar
• Robertson TE, Nouraie M, Qin S, et al. HIV infection is an independent risk factor for decreased 6-minute walk test distance. PLoS One. 2019;14(4):e0212975.
   PubMed Web of Science ®Google Scholar
• Diaz PT, Wewers MD, Pacht E, et al. Respiratory symptoms among HIV-seropositive individuals. Chest. 2003 Jun;;123(6):1977–1982.
   PubMed Web of Science ®Google Scholar
• Drummond MB, Kirk GD, Ricketts EP, et al. Cross sectional analysis of respiratory symptoms in an injection drug user cohort: the impact of obstructive lung disease and HIV. BMC Pulm Med. 2010 May ;11(10):27.
   Google Scholar
• Brown J, Roy A, Harris R, et al. Respiratory symptoms in people living with HIV and the effect of antiretroviral therapy: a systematic review and meta-analysis. Thorax. 2017 Apr;;72(4):355–366.
   PubMed Web of Science ®Google Scholar
• Brown J, McGowan JA, Chouial H, et al. Respiratory health status is impaired in UK HIV-positive adults with virologically suppressed HIV infection. HIV Med. 2017 Sep;;18(8):604–612.
   PubMed Web of Science ®Google Scholar
• Sabin CA, Kunisaki KM, Bagkeris E, et al. Respiratory symptoms and chronic bronchitis in people with and without HIV infection. HIV Med. 2020; Epub ahead of print 2020 6 9 DOI:10.1111/hiv.12955
   Web of Science ®Google Scholar
• CDC. Smoking is down, but almost 38 million american adults still smoke: center for disease control and prevention; january 18, 2018 [ Access date: 2020 Sept 20]. Available from: https://www.cdc.gov/media/releases/2018/p0118-smoking-rates-declining.html
   Google Scholar
• Lambert AA, Kirk GD, Astemborski J, et al. HIV infection is associated with increased risk for acute exacerbation of COPD. J Acquir Immune Defic Syndr. 2015 May 1;69(1):68–74.
   PubMed Web of Science ®Google Scholar
• Raynaud C, Roche N, Chouaid C. Interactions between HIV infection and chronic obstructive pulmonary disease: clinical and epidemiological aspects. Respir Res. 2011 Sep ;1(12):117.
   Google Scholar
• Mdodo R, Frazier EL, Dube SR, et al. Cigarette smoking prevalence among adults with HIV compared with the general adult population in the United States: cross-sectional surveys. Ann Intern Med. 2015 Mar 3;162(5):335–344.
   PubMed Web of Science ®Google Scholar
• Pacek LR, Crum RMA. Review of the literature concerning HIV and cigarette smoking: morbidity and mortality, associations with individual- and social-level characteristics, and smoking cessation efforts. Addict Res Theory. 2015 Feb;;23(1):10–23.
   PubMed Web of Science ®Google Scholar
• Cioe PA, Baker J, Kojic EM, et al. Elevated soluble CD14 and lower d-dimer are associated with cigarette smoking and heavy episodic alcohol use in persons living with HIV. J Acquir Immune Defic Syndr. 2015 Dec 1;70(4):400–405.
   PubMed Web of Science ®Google Scholar
• Helleberg M, May MT, Ingle SM, et al. Smoking and life expectancy among HIV-infected individuals on antiretroviral therapy in Europe and North America. AIDS. 2015 Jan 14;29(2):221–229.
   PubMed Web of Science ®Google Scholar
• Reddy KP, Parker RA, Losina E, et al. Impact of cigarette smoking and smoking cessation on life expectancy among people with HIV: a us-based modeling study. J Infect Dis. 2016 Dec 1;214(11):1672–1681.
   PubMed Web of Science ®Google Scholar
• Crothers K, Griffith TA, McGinnis KA, et al. The impact of cigarette smoking on mortality, quality of life, and comorbid illness among HIV-positive veterans. J Gen Intern Med. 2005 Dec;;20(12):1142–1145.
   PubMed Web of Science ®Google Scholar
• Altekruse SF, Shiels MS, Modur SP, et al. Cancer burden attributable to cigarette smoking among HIV-infected people in North America. AIDS. 2018 Feb 20;32(4):513–521.
   PubMed Web of Science ®Google Scholar
• De P, Farley A, Lindson N, et al. Systematic review and meta-analysis: influence of smoking cessation on incidence of pneumonia in HIV. BMC Med. 2013 Jan ;22(11):15.
   Google Scholar
• Brown J, Pickett E, Smith C, et al. The effect of HIV status on the frequency and severity of acute respiratory illness. PLoS One. 2020;15(5):e0232977.
   PubMed Web of Science ®Google Scholar
• van Zyl-smit RN, Brunet L, Pai M, et al. The convergence of the global smoking, COPD, tuberculosis, HIV, and respiratory infection epidemics. Infect Dis Clin North Am. 2010 Sep;;24(3):693–703.
   PubMed Web of Science ®Google Scholar
• Attia EF, McGinnis KA, Feemster LC, et al. Association of COPD with risk for pulmonary infections requiring hospitalization in HIV-infected veterans. J Acquir Immune Defic Syndr. 2015;70(3): 280–288.
   PubMed Web of Science ®Google Scholar
• Jary HR, Aston S, Ho A, et al. Household air pollution, chronic respiratory disease and pneumonia in malawian adults: A case-control study. Wellcome Open Res. 2017;2:103.
   PubMedGoogle Scholar
• Halonen JI, Lanki T, Yli-Tuomi T, et al. Urban air pollution, and asthma and COPD hospital emergency room visits. Thorax. 2008 Jul;;63(7):635–641.
   PubMed Web of Science ®Google Scholar
• Ocakli B, Acarturk E, Aksoy E, et al. The impact of exposure to biomass smoke versus cigarette smoke on inflammatory markers and pulmonary function parameters in patients with chronic respiratory failure. Int J Chron Obstruct Pulmon Dis. 2018;13:1261–1267.
   PubMed Web of Science ®Google Scholar
• Peacock JL, Anderson HR, Bremner SA, et al. Outdoor air pollution and respiratory health in patients with COPD. Thorax. 2011 Jul;;66(7):591–596.
   PubMed Web of Science ®Google Scholar
• Song Q, Christiani DC, XiaorongWang RJ. The global contribution of outdoor air pollution to the incidence, prevalence, mortality and hospital admission for chronic obstructive pulmonary disease: a systematic review and meta-analysis. Int J Environ Res Public Health. 2014 Nov 14;11(11):11822–11832.
   PubMed Web of Science ®Google Scholar
• Zanobetti A, Bind MA, Schwartz J. Particulate air pollution and survival in a COPD cohort. Environ Health. 2008 Oct ;10(7):48.
   Google Scholar
• Capistrano SJ, van Reyk D, Chen H, et al. Evidence of biomass smoke exposure as a causative factor for the development of COPD. Toxics. 2017 Dec 1;5(4):4.
   Web of Science ®Google Scholar
• Blount RJ, Djawe K, Daly KR, et al. Ambient air pollution associated with suppressed serologic responses to Pneumocystis jirovecii in a prospective cohort of HIV-infected patients with Pneumocystis pneumonia. PLoS One. 2013;8(11):e80795.
   PubMed Web of Science ®Google Scholar
• Alvaro-Meca A, Palomares-Sancho I, Diaz A, et al. Pneumocystis pneumonia in HIV-positive patients in Spain: epidemiology and environmental risk factors. J Int AIDS Soc. 2015;18(1):19906.
   PubMedGoogle Scholar
• Djawe K, Levin L, Swartzman A, et al. Environmental risk factors for Pneumocystis pneumonia hospitalizations in HIV patients. Clin Infect Dis. 2013 Jan;;56(1):74–81.
   PubMed Web of Science ®Google Scholar
• Suter MK, Karr CJ, John-Stewart GC, et al. Implications of combined exposure to household air pollution and HIV on neurocognition in children. Int J Environ Res Public Health. 2018 Jan 20;15(1):1.
   Web of Science ®Google Scholar
• North CM, MacNaughton P, Lai PS, et al. Personal carbon monoxide exposure, respiratory symptoms, and the potentially modifying roles of sex and HIV infection in rural Uganda: a cohort study. Environ Health. 2019 Aug 20;18(1):73.
   PubMed Web of Science ®Google Scholar
• Fitzpatrick ME, Kunisaki KM, Morris A. Pulmonary disease in HIV-infected adults in the era of antiretroviral therapy. AIDS. 2018 Jan 28;32(3):277–292.
   PubMed Web of Science ®Google Scholar
• Singhvi D, Bon J, Morris A. Obstructive lung disease in HIV-phenotypes and pathogenesis. Curr HIV/AIDS Rep. 2019 Aug;;16(4):359–369.
   PubMed Web of Science ®Google Scholar
• Besutti G, Raggi P, Zona S, et al. Independent association of subclinical coronary artery disease and emphysema in HIV-infected patients. HIV Med. 2016 Mar;;17(3):178–187.
   PubMed Web of Science ®Google Scholar
• Louie JK, Hsu LC, Osmond DH, et al. Trends in causes of death among persons with acquired immunodeficiency syndrome in the era of highly active antiretroviral therapy, san francisco, 1994-1998. J Infect Dis. 2002;186(7):1023–1027.
   PubMed Web of Science ®Google Scholar
• Benard A, Mercie P, Alioum A, et al. Bacterial pneumonia among HIV-infected patients: decreased risk after tobacco smoking cessation. ANRS CO3 Aquitaine Cohort. 2010 Jan 26;5(1):e8896. 2000-2007. PLoS One.
   Google Scholar
• Petoumenos K, Worm S, Reiss P, et al. Rates of cardiovascular disease following smoking cessation in patients with HIV infection: results from the D:A:D study(*). HIV Med. 2011 Aug;;12(7):412–421.
   PubMed Web of Science ®Google Scholar
• Shahrir S, Tindle HA, McGinnis KA, et al. Contemplation of smoking cessation and quit attempts in human immunodeficiency virus-infected and uninfected veterans. Subst Abus. 2016 Apr-Jun;;37(2):315–322.
   PubMed Web of Science ®Google Scholar
• Ledgerwood DM, Yskes R. Smoking cessation for people living with HIV/AIDS: a literature review and synthesis. Nicotine Tob Res. 2016 Dec;;18(12):2177–2184.
   PubMed Web of Science ®Google Scholar
• Pool ER, Dogar O, Lindsay RP, et al. Interventions for tobacco use cessation in people living with HIV and AIDS. Cochrane Database Syst Rev. 2016 Jun ;13(6):CD011120.
   Google Scholar
• Ashare RL, Thompson M, Leone F, et al. Differences in the rate of nicotine metabolism among smokers with and without HIV. AIDS. 2019 May 1;33(6):1083–1088.
   PubMed Web of Science ®Google Scholar
• Thomas KH, Martin RM, Knipe DW, et al. Risk of neuropsychiatric adverse events associated with varenicline: systematic review and meta-analysis. BMJ. 2015 Mar ;12(350):h1109.
   Google Scholar
• Thompson M, Schnoll R, Serrano K, et al. The effect of varenicline on mood and cognition in smokers with HIV. Psychopharmacol (Berl). 2020 Apr;;237(4):1223–1231.
   PubMed Web of Science ®Google Scholar
• Salvi SS, Barnes PJ. Chronic obstructive pulmonary disease in non-smokers. Lancet. 2009 Aug 29;374(9691):733–743.
   PubMed Web of Science ®Google Scholar
• Romieu I, Riojas-Rodriguez H, Marron-Mares AT, et al. Improved biomass stove intervention in rural Mexico: impact on the respiratory health of women. Am J Respir Crit Care Med. 2009 Oct 1;180(7):649–656.
   PubMed Web of Science ®Google Scholar
• Kunisaki KM, Baker JV, Collins G, et al. Lung function decline in early HIV infection: impact of antiretroviral drug timing and drug regimen. Am J Respir Crit Care Med. 2020 Mar 15;201(6):739–741.
   PubMed Web of Science ®Google Scholar
• Hoy JF, Grund B, Roediger M, et al. Immediate initiation of antiretroviral therapy for HIV infection accelerates bone loss relative to deferring therapy: findings from the start bone mineral density substudy, a randomized trial. J Bone Miner Res. 2017 Sep;;32(9):1945–1955.
   PubMed Web of Science ®Google Scholar
• Mills A, Arribas JR, Andrade-Villanueva J, et al. Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in antiretroviral regimens for virologically suppressed adults with HIV-1 infection: a randomised, active-controlled, multicentre, open-label, phase 3, non-inferiority study. Lancet Infect Dis. 2016 Jan;16(1):43–52.
   PubMed Web of Science ®Google Scholar
• US Preventive Services Task Force (USPSTF). Screening for chronic obstructive pulmonary disease: US preventive services task force recommendation statement. JAMA. 2016 Apr 5;315(13):1372–1377.
   PubMed Web of Science ®Google Scholar
• Qaseem A, Wilt TJ, Weinberger SE, et al. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the american college of physicians, american college of chest physicians, american thoracic society, and european respiratory society. Ann Intern Med. 2011 Aug 2;155(3):179–191.
   PubMed Web of Science ®Google Scholar
• Shirley DK, Kaner RJ, Glesby MJ. Screening for chronic obstructive pulmonary disease (COPD) in an urban HIV clinic: a pilot study. AIDS Patient Care STDS. 2015 May;;29(5):232–239.
   PubMed Web of Science ®Google Scholar
• Lambert AA, Drummond MB, Kisalu A, et al. Implementation of a COPD screening questionnaire in an outpatient HIV Clinic. COPD. 2016 Dec;;13(6):767–772.
   PubMedGoogle Scholar
• Quiros-Roldan E, Pezzoli MC, Berlendis M, et al. A COPD case-finding program in a large cohort of HIV-infected persons. Respir Care. 2019 Feb;;64(2):169–175.
   PubMed Web of Science ®Google Scholar
• Anthonisen NR, Skeans MA, Wise RA, et al. The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial. Ann Inter Med. 2005 Feb 15;142(4):233–239.
   PubMed Web of Science ®Google Scholar
• Working Party MRC. Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Lancet. 1981 Mar 28;1(8222):681–686.
   PubMed Web of Science ®Google Scholar
• NOTT. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Nocturnal oxygen therapy trial group. Ann Intern Med. 1980 Sep;;93(3):391–398.
   PubMed Web of Science ®Google Scholar
• Kew KM, Seniukovich A. Inhaled steroids and risk of pneumonia for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2014 Mar ;10(3):CD010115.
   Google Scholar
• Loke YK, Cavallazzi R, Singh S. Risk of fractures with inhaled corticosteroids in COPD: systematic review and meta-analysis of randomised controlled trials and observational studies. Thorax. 2011 Aug;;66(8):699–708.
   PubMed Web of Science ®Google Scholar
• Kedem E, Shahar E, Hassoun G, et al. syndrome due to coadministration of ritonavir and inhaled budesonide in an asthmatic human immunodeficiency virus infected patient. J Asthma. 2010 Sep;;47(7):830–831.
   PubMed Web of Science ®Google Scholar
• Boyd SD, Hadigan C, McManus M, et al. Influence of low-dose ritonavir with and without darunavir on the pharmacokinetics and pharmacodynamics of inhaled beclomethasone. J Acquir Immune Defic Syndr. 2013 Jul 1;63(3):355–361.
   PubMed Web of Science ®Google Scholar
• Poole PJ, Chacko E, Wood-Baker RW, et al. Influenza vaccine for patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2006 Jan ;25(1):CD002733.
   Google Scholar
• Walters JA, Tang JN, Poole P, et al. Pneumococcal vaccines for preventing pneumonia in chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2017 Jan ;24(1):CD001390.
   Google Scholar
• Panel on Opportunistic Infections in Adults and Adolescents with HIV. Guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV: recommendations from the centers for disease control and prevention, the national institutes of health, and the HIV medicine association of the infectious diseases society of america. Available at http://aidsinfo.nih.gov/contentfiles/lvguidelines/adult_oi.pdf. Access date: 2020 Sept 6.
   Google Scholar
• Dobler CC, Morrow AS, Beuschel B, et al. Pharmacologic therapies in patients with exacerbation of chronic obstructive pulmonary disease: a systematic review with meta-analysis. Ann Intern Med. 2020 Mar 17;172(6):413–422.
   PubMed Web of Science ®Google Scholar
• Morris A, Fitzpatrick M, Bertolet M, et al. Use of rosuvastatin in HIV-associated chronic obstructive pulmonary disease. AIDS. 2017 Feb 20;31(4):539–544.
   PubMed Web of Science ®Google Scholar